Research Leads to New Medical Guidelines
A landmark research study to prevent the development of peanut allergy, from the Immune Tolerance Network (ITN), has led to new medical guidelines for health care providers. Benaroya Research Institute leads the ITN with BRI Member and scientist Gerald Nepom, MD, PhD, serving as the director.
The guidelines, developed by an expert panel from the National Institutes of Health, were based on the groundbreaking Learning Early About Peanut (LEAP) study. The research showed that regular peanut consumption begun in infancy and continued until 5 years of age led to an 81 percent reduction in development of peanut allergy in infants deemed at high risk because they already had severe eczema, egg allergy or both. For more information, visit the peanut allergy news article.